Skip to main content
. 2019 Apr 15;202(10):2888–2906. doi: 10.4049/jimmunol.1800583

FIGURE 7.

FIGURE 7.

Treatment with evobrutinib normalized clinical chemistry and hematology parameters. (A) Urea nitrogen, albumin, and cholesterol levels in NZB/W mice treated with evobrutinib, CellCept, or vehicle on day 56. Normal control (NC), young NZB/W mice not yet showing signs of proteinuria. (B) Numbers of RBCs, hemoglobin, and hematocrit in the same animals. One-way ANOVA with Dunnett posttest was performed for treated groups compared with vehicle. *p < 0.05, **p < 0.01, ***p < 0.001.